
Costs and benefits of tumor testing for mutations in high-grade serous ovarian cancer as a companion diagnostic for PARP inhibitor treatment
Kwon, J.S., Tinker, A.V., Karsan, A., Schrader, K.A., Sun, S.Volume:
154
Langue:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.04.411
Date:
June, 2019
Fichier:
PDF, 498 KB
english, 2019